Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) 9.9% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has approved Vanda's ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Morgan Stanley Remains Sidelined on Ulta Salon (ULTA) - PT to $230 May 27, 2016 1:13 PM Brean Capital Remains Bullish on Deckers Outdoor (DECK) Following Strong 4Q Results May 27, 2016 9:52 AM Jefferies Raises Price Target on Ulta Salon (ULTA) to $215; Remains Sidelined May 27, 2016 8:51 AM Jefferies Reiterates Buy on Deckers Outdoor (DECK) Following 4Q May 27, 2016 8:37 AM Piper Jaffray Remains Bullish on Palo Alto Networks (PANW) Following 3Q - PT to $167 May 27, 2016 8:13 AM Piper Jaffray Remains Bullish on Palo Alto Networks (PANW) Following 3Q - PT to $167 May 27, 2016 8:11 AM Piper Jaffray Raises Price Target on Deckers Outdoor (DECK) Following 4Q May 27, 2016 8:01 AM Baird Remains Bullish on Palo Alto Networks (PANW) Following Solid 3Q and In-Line Guidance May 27, 2016 7:14 AM Sterne Agee CRT Remains Sidelined on GameStop (GME) as Guidance Overshadows 1Q Results May 27, 2016 6:52 AM Needham & Company Remains Sidelined on Splunk (SPLK) Following 1Q Revenue Beat and Raise May 27, 2016 6:42 AM